Safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease

Поділитися
Вставка
  • Опубліковано 27 вер 2024
  • Dr Tuttle presents a recent evaluation of the safety of empagliflozin in in patients with both type 2 diabetes and chronic kidney disease.
    Subscribe: www.youtube.co...
    Visit The Video Journal of Biomedicine: www.biomedicin...
    Follow us on Twitter: / vjofbiomedicine
    LinkedIn: / video-journal-of-biome...
    Facebook: / videojournalbiomedicine
    #t2d #t2dm #ckd #empagliflozin #SGLT2i #diabetes #kidneydisease #chronickidneydisease

КОМЕНТАРІ •